Feedback / Questions
navicixizumab (OMP-305B83) - OncXerna Therap
"A11: Navicixizumab phase I in #CRCSM #CRCTrialsChat"
(@IglesiaMichael)
Feb 16, 2023
P1 data
•
Colorectal Cancer
https://twitter.com/IglesiaMichael/status/1626403394549055490
Feb 16, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious